Enhancement drugs: are there limits to what we should enhance and why?
-
Correspondence: Morten Hesse mh@crf.au.dk
BMC Medicine 2010, 8:50 doi:10.1186/1741-7015-8-50
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 13 Jul 2010 | |
| Editorial acceptance | 16 Jul 2010 | ||
| Published | 03 Aug 2010 |